Insider Buying: Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Director Purchases $181,100.00 in Stock

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) Director Michael R. Hayden purchased 5,000 shares of the company’s stock in a transaction that occurred on Monday, December 23rd. The shares were acquired at an average cost of $36.22 per share, with a total value of $181,100.00. Following the completion of the acquisition, the director now […]

Leave a Reply

Your email address will not be published.

Previous post Insider Buying: Benitec Biopharma Inc. (NASDAQ:BNTC) Director Acquires $301,971.96 in Stock
Next post Discover Financial Services Board Approves One-Time Cash Award for Interim CEO